StockSelector.com
  Research, Select, & Monitor Thursday, April 18, 2019 8:15:13 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Aclaris Therapeutics, Inc.$5.19($.31)(5.64%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Aclaris Therapeutics, Inc. has an overall rank of 6486 out of 6827 stocks based on 5 positive rankings and 8 negative rankings.

Positive Rankings
Estimated Revenue Growth
Aclaris Therapeutics rank is 56
Oversold Stochastics
Aclaris Therapeutics rank is 410
Debt-to-Equity
Aclaris Therapeutics rank is 607
Low Put/Call
Aclaris Therapeutics has a low Put/Call ratio of 0.21 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Aclaris Therapeutics is ranked 629.
Price-to-Book
Aclaris Therapeutics rank is 841
Negative Rankings
Down EPS Surprise
Aclaris Therapeutics missed the consensus earnings estimate when it last reported quarterly earnings.
Negative Net Margin
Aclaris Therapeutics rank is 151
10 Day Loss
Aclaris Therapeutics rank is 205
90 Day Loss
Aclaris Therapeutics rank is 266
Price-to-Sales
Aclaris Therapeutics rank is 271
Negative ROA
Aclaris Therapeutics rank is 467
Negative ROE
Aclaris Therapeutics rank is 502
High vPut/Call
Aclaris Therapeutics has a high Put/Call ratio of 0.47 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Aclaris Therapeutics is ranked 2077.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.